Literature DB >> 27437882

The Safety of Dipeptidyl Peptidase 4 Inhibitors and the Risk for Heart Failure.

Benjamin M Scirica1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27437882     DOI： 10.1001/jamacardio.2016.0184

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  8 in total

Review 1.  Effect of glucose-lowering therapies on heart failure.

Authors:  Michael Nassif; Mikhail Kosiborod
Journal:  Nat Rev Cardiol       Date:  2018-01-25       Impact factor: 32.419

2.  Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.

Authors:  David D Berg; Stephen D Wiviott; Benjamin M Scirica; Yared Gurmu; Ofri Mosenzon; Sabina A Murphy; Deepak L Bhatt; Lawrence A Leiter; Darren K McGuire; John P H Wilding; Per Johanson; Peter A Johansson; Anna Maria Langkilde; Itamar Raz; Eugene Braunwald; Marc S Sabatine
Journal:  Circulation       Date:  2019-08-31       Impact factor: 29.690

Review 3.  Interpreting Absolute and Relative Risk Reduction in the Context of Recent Cardiovascular Outcome Trials in Patients with Type 2 Diabetes.

Authors:  David D Berg; Ahmed A Kolkailah; Ashish Sarraju; Anne Marie Kerchberger; Mahmoud Eljalby; Darren K McGuire
Journal:  Curr Diab Rep       Date:  2021-11-06       Impact factor: 4.810

Review 4.  DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics.

Authors:  Chayakrit Krittanawong; Andrew Xanthopoulos; Takeshi Kitai; Natalia Branis; HongJu Zhang; Marrick Kukin
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

5.  Recent cardiovascular outcome trials of antidiabetic drugs: A comparative analysis.

Authors:  Awadhesh Kumar Singh; Ritu Singh
Journal:  Indian J Endocrinol Metab       Date:  2017 Jan-Feb

6.  Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.

Authors:  Ming Zhao; Jiayi Chen; Yanyan Yuan; Zuquan Zou; Xiaolong Lai; Daud M Rahmani; Fuyan Wang; Yang Xi; Qin Huang; Shizhong Bu
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

7.  Comparative Cardiovascular Risks of Dipeptidyl Peptidase-4 Inhibitors: Analyses of Real-world Data in Korea.

Authors:  Kyoung Hwa Ha; Bongseong Kim; Hae Sol Shin; Jinhee Lee; Hansol Choi; Hyeon Chang Kim; Dae Jung Kim
Journal:  Korean Circ J       Date:  2018-02-27       Impact factor: 3.243

Review 8.  The effects of antidiabetic agents on heart failure.

Authors:  M Wijnen; E J J Duschek; H Boom; M van Vliet
Journal:  Neth Heart J       Date:  2021-06-07       Impact factor: 2.380
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.